Large cap
Welspun Corp files its earnings call transcript. It's the same story.
The May 22 transcript is a compliance filing. It contains nothing new beyond the prior summary.
Sundaram Finance profit up 19%, dividend steady at ₹40
Standalone PAT of ₹1,834 crore on 18% revenue growth. Gross bad loans stable at 1.44%. Routine numbers for a steady business.
Suzlon's order book hits 5.9 GW, but it missed its own market-share target.
Record FY26 turbine deliveries and a ₹16,679 cr revenue year, yet management conceded it commissioned only 744 MW against a 1,500 MW target for wind installations.
RVNL profit drops 33% to ₹800 cr as auditor flags ₹1,116 cr disputed receivable
Fourth-quarter profit fell 43% on flat annual revenue. The board approved a final dividend and is shutting its Kyrgyzstan subsidiary.
NHPC's ₹3,766 cr profit has a tax gain. The real money is stuck at Parbati-II.
The headline profit was inflated by a one-off. The key operational catalysts—a ₹300 crore tariff unlock and Teesta-V's return—are still ahead.
Suzlon's annual revenue surges 54% to ₹16,679 cr on record turbine deliveries
The wind-energy company delivered a record 2,456 MW of turbines in India last year, driving profit before tax up 67% and leaving it with a ₹2,384 cr net cash pile.
LIC crosses 5% in Central Bank of India
The nation's largest insurer accumulated another 2.9% of the public sector bank on the open market, triggering a mandatory SEBI disclosure.
Narayana Hrudayalaya clears FY26 results and debt plans
Board finalizes previously disclosed results, approves a ₹1,500 cr debt raise, and holds the dividend steady.
Narayana Hrudayalaya confirms FY26 numbers as expected
The health provider's full-year results add no new data, showing the impact of the UK acquisition already priced in by the market.
Narayana Hrudayalaya consolidated revenue jumps 44% on UK acquisition
Standalone growth hit 10.7% as the company integrated Practice Plus Group; dividend remains flat at ₹4.50.
Narayana Hrudayalaya consolidated revenue jumps 44% on UK acquisition
Standalone net profit rose 16.7% as the company closed its first full year following the November 2025 entry into the UK market.
Narayana Hrudayalaya grows profit 17% in FY26
The hospital chain posts steady annual growth and secures a ₹1,500 crore debt-raising limit.
Fortis Healthcare reports 31.5% profit growth for FY26
A routine regulatory filing confirms previously released annual figures and declares a ₹1 per share final dividend.
Fortis Healthcare profits climb 31% on double-digit revenue growth
FY26 consolidated revenue hit ₹9,128 crore, with the board proposing a final dividend of ₹1 per share.
Fortis Healthcare confirms final dividend of ₹1 per share
The company cleared routine year-end business, including cost auditor appointments and CSR policies, following its earlier earnings release.
Colgate-Palmolive India's routine recap adds nothing new
A newsletter summarizing already-disclosed Q4 results and a dividend of ₹24 per share.
Fortis Healthcare reports steady results with no surprises
The company’s investor presentation confirms earlier Q4 disclosures, with revenue growing 17.8% and EBITDA margins steady at 22.5%.
Fortis Healthcare profit hits ₹1,064 crore as hospital revenue jumps
Annual revenue reached ₹9,128 crore, led by a 19.1% gain in hospital income, with the board declaring a dividend of ₹1 per share.
Fortis Healthcare profit climbs 31.5% to ₹1,064 crore in FY26
Consolidated revenue grew 17.3% as the hospital chain wrapped its fiscal year with an unmodified audit opinion.
Ramco Cements sets ₹800 cr capex for FY27 to reach 31 MTPA capacity
The company targets capacity growth after liquidating ₹1,098 cr in assets.
Fortis Healthcare approves Q4 results and a ₹1 dividend
The company posted year-on-year growth for FY2026, but the filing contains no material surprises for investors.
Ramco Cements sets ₹800 cr capex for FY27
The company faces persistent cost pressures from pet coke, gypsum, and diesel, though the guidance holds no major surprises.
Amber Enterprises earnings transcript adds nothing new
Management's recent call transcript contains no material information beyond what the market already processed on May 18.
Ramco Cements FY26 profit jumps to ₹694 cr on land sales
A ₹553 cr gain from surplus land sales pushed bottom-line growth, as the company prioritized balance sheet repair.
Ramco Cements profit jumps to ₹694 cr in FY26
Audited results confirm growth in revenue and profit, alongside a dividend payout of ₹2.50 per share.